Effect of pistachio consumption on plasma lipoprotein subclasses in pre-diabetic subjects

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 25, Issue 4, 2015, Pages 396-402

  Hernandez Alonso P ^a,b   Salas Salvado J ^a,b   Baldrich Mora, M ^a,b   Mallol, R ^a   Correig, X ^a   Bullo M ^a,b  

^a UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

Cardiovascular disease; Clinical trial; Dietary intervention; Lipoprotein; Pistachios; Pre diabetes

Indexed keywords

LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN; CARBOHYDRATE DIET; FAT INTAKE; GLUCOSE BLOOD LEVEL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIET; FEMALE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PISTACHIO; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; ADMINISTRATION AND DOSAGE; AGED; ATHEROSCLEROSIS; BLOOD; BLOOD PRESSURE; BODY MASS; CARBOHYDRATE DIET; CARDIOVASCULAR DISEASES; CROSSOVER PROCEDURE; FAT INTAKE; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUT; PISTACIA; WAIST CIRCUMFERENCE;

PISTACIA VERA;

ADULT; AGED; ATHEROSCLEROSIS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-OVER STUDIES; DIETARY CARBOHYDRATES; DIETARY FATS; FEMALE; HUMANS; INSULIN; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NUTS; PISTACIA; PREDIABETIC STATE; RISK FACTORS; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 84933680154     PISSN: 09394753     EISSN: 15903729     Source Type: Journal    
DOI: 10.1016/j.numecd.2015.01.013     Document Type: Article

References (31)

1. Festa A., Williams K., Hanley A.J.G., Otvos J.D., Goff D.C., Wagenknecht L.E., et al. Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the insulin resistance atherosclerosis study. Circulation 2005, 111:3465-3472. 10.1161/CIRCULATIONAHA.104.512079.
2. Martin S.S., Jones S.R., Toth P.P. High-density lipoprotein subfractions: current views and clinical practice applications. Trends Endocrinol Metab 2014, 25:329-336. 10.1016/j.tem.2014.05.005.
3. Chei C.-L., Yamagishi K., Kitamura A., Kiyama M., Imano H., Ohira T., et al. High-density lipoprotein subclasses and risk of stroke and its subtypes in Japanese population: the circulatory risk in communities study. Stroke 2013, 44:327-333. 10.1161/STROKEAHA.112.674812.
4. Rizzo M., Berneis K. Low-density lipoprotein size and cardiovascular risk assessment. QJM 2006, 99:1-14. 10.1093/qjmed/hci154.
5. Sabaté J., Oda K., Ros E. Nut consumption and blood lipid levels: a pooled analysis of 25 intervention trials. Arch Intern Med 2010, 170:821-827. 10.1001/archinternmed.2010.79.
6. Almario R.U., Vonghavaravat V., Wong R., Kasim-Karakas S.E. Effects of walnut consumption on plasma fatty acids and lipoproteins in combined hyperlipidemia. Am J Clin Nutr 2001, 74:72-79.
7. Bulló M., Juanola-Falgarona M., Hernández-Alonso P., Salas-Salvadó J. Nutrition attributes and health effects of pistachio nuts. Br J Nutr 2015, [in press].
8. Hernández-Alonso P., Salas-Salvadó J., Baldrich-Mora M., Juanola-Falgarona M., Bulló M. Beneficial effect of pistachio consumption on glucose metabolism, insulin resistance, inflammation, and related metabolic risk markers: a randomized clinical trial. Diabetes Care 2014, 37:3098-3105. 10.2337/dc14-1431.
9. 1H NMR spectroscopy. J Lipid Res 2015, jlr.D050120. 10.1194/jlr.D050120.
10. Banel D.K., Hu F.B. Effects of walnut consumption on blood lipids and other cardiovascular risk factors: a meta-analysis and systematic review. Am J Clin Nutr 2009, 90:56-63. 10.3945/ajcn.2009.27457.
11. Tapsell L.C., Gillen L.J., Patch C.S., Batterham M., Owen A., Baré M., et al. Including walnuts in a low-fat/modified-fat diet improves HDL cholesterol-to-total cholesterol ratios in patients with type 2 diabetes. Diabetes Care 2004, 27:2777-2783. 10.2337/diacare.27.12.2777.
12. Casas-Agustench P., López-Uriarte P., Bulló M., Ros E., Cabré-Vila J.J., Salas-Salvadó J. Effects of one serving of mixed nuts on serum lipids, insulin resistance and inflammatory markers in patients with the metabolic syndrome. Nutr Metab Cardiovasc Dis 2011, 21:126-135. 10.1016/j.numecd.2009.08.005.
13. Kocyigit A., Koylu A.A., Keles H. Effects of pistachio nuts consumption on plasma lipid profile and oxidative status in healthy volunteers. Nutr Metab Cardiovasc Dis 2006, 16:202-209. 10.1016/j.numecd.2005.08.004.
14. Sheridan M.J., Cooper J.N., Erario M., Cheifetz C.E. Pistachio nut consumption and serum lipid levels. J Am Coll Nutr 2007, 26:141-148.
15. Sari I., Baltaci Y., Bagci C., Davutoglu V., Erel O., Celik H., et al. Effect of pistachio diet on lipid parameters, endothelial function, inflammation, and oxidative status: a prospective study. Nutrition 2010, 26:399-404. 10.1016/j.nut.2009.05.023.
16. Pihlajamäki J., Gylling H., Miettinen T.A., Laakso M. Insulin resistance is associated with increased cholesterol synthesis and decreased cholesterol absorption in normoglycemic men. J Lipid Res 2004, 45:507-512. 10.1194/jlr.M300368-JLR200.
17. Liu J., Sempos C., Donahue R.P., Dorn J., Trevisan M., Grundy S.M. Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes. Diabetes Care 2005, 28:1916-1921.
18. Liu J., Sempos C.T., Donahue R.P., Dorn J., Trevisan M., Grundy S.M. Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease. Am J Cardiol 2006, 98:1363-1368. 10.1016/j.amjcard.2006.06.032.
19. Abd-Allha E., Hassan B.B., Abduo M., Omar S.A., Sliem H. Small dense low-density lipoprotein as a potential risk factor of nephropathy in type 2 diabetes mellitus. Indian J Endocrinol Metab 2014, 18:94-98. 10.4103/2230-8210.126585.
20. Nagai K., Yamagata K., Ohkubo R., Saito C., Asahi K., Iseki K., et al. Annual decline in estimated glomerular filtration rate is a risk factor for cardiovascular events independent of proteinuria. Nephrology 2014, 19:574-580. 10.1111/nep.12286.
21. Rizzo M., Otvos J., Nikolic D., Montalto G., Toth P.P., Banach M. Subfractions and subpopulations of HDL: an update. Curr Med Chem 2014, 21:2881-2891.
22. Voros S., Joshi P., Qian Z., Rinehart S., Vazquez-Figueroa J.G., Anderson H., et al. Apoprotein B, small-dense LDL and impaired HDL remodeling is associated with larger plaque burden and more noncalcified plaque as assessed by coronary CT angiography and intravascular ultrasound with radiofrequency backscatter: results from the ATLANTA I. J Am Heart Assoc 2013, 2:e000344. 10.1161/JAHA.113.000344.
23. Friedlander Y., Kidron M., Caslake M., Lamb T., McConnell M., Bar-On H. Low density lipoprotein particle size and risk factors of insulin resistance syndrome. Atherosclerosis 2000, 148:141-149.
24. Garvey W.T., Kwon S., Zheng D., Shaughnessy S., Wallace P., Hutto A., et al. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes 2003, 52:453-462.
25. Goff D.C., D'Agostino R.B., Haffner S.M., Otvos J.D. Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the insulin resistance atherosclerosis study. Metabolism 2005, 54:264-270. 10.1016/j.metabol.2004.09.002.
26. Berglund L., Oliver E.H., Fontanez N., Holleran S., Matthews K., Roheim P.S., et al. HDL-subpopulation patterns in response to reductions in dietary total and saturated fat intakes in healthy subjects. Am J Clin Nutr 1999, 70:992-1000.
27. Lamarche B., Desroches S., Jenkins D.J.A., Kendall C.W.C., Marchie A., Faulkner D., et al. Combined effects of a dietary portfolio of plant sterols, vegetable protein, viscous fibre and almonds on LDL particle size. Br J Nutr 2004, 92:657-663.
28. Guay V., Lamarche B., Charest A., Tremblay A.J., Couture P. Effect of short-term low- and high-fat diets on low-density lipoprotein particle size in normolipidemic subjects. Metabolism 2012, 61:76-83. 10.1016/j.metabol.2011.06.002.
29. Wojczynski M.K., Glasser S.P., Oberman A., Kabagambe E.K., Hopkins P.N., Tsai M.Y., et al. High-fat meal effect on LDL, HDL, and VLDL particle size and number in the Genetics of Lipid-Lowering Drugs and Diet Network (GOLDN): an interventional study. Lipids Health Dis 2011, 10:181. 10.1186/1476-511X-10-181.
30. Di Angelantonio E., Sarwar N., Perry P., Kaptoge S., Ray K.K., Thompson A., et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA 2009, 302:1993-2000. 10.1001/jama.2009.1619.
31. Arsenault B.J., Lemieux I., Després J.-P., Wareham N.J., Stroes E.S.G., Kastelein J.J.P., et al. Comparison between gradient gel electrophoresis and nuclear magnetic resonance spectroscopy in estimating coronary heart disease risk associated with LDL and HDL particle size. Clin Chem 2010, 56:789-798. 10.1373/clinchem.2009.140939.